FDA Inspection
Dario D. Altamirano, DODario D. Altamirano, DO – FDA Inspection, Sep 21, 2018
Record Details
This FDA Inspection record concerns Dario D. Altamirano, DO, with an inspection on September 21, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 49ae984b-e792-4681-af3d-2e79ffefe8df
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1066302
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dario D. Altamirano, DO
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 21, 2025 | Not classified | Florida District Office | |
| February 9, 2022 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 28, 2013 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 3, 2011 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Dario D. Altamirano, DO
- FDA Inspection 1279838 - 2025-08-21
- FDA Inspection 1161913 - 2022-02-09
- FDA Inspection 838564 - 2013-06-28
- FDA Inspection 754975 - 2011-11-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.